# Treatment of Children With Insufficient Secretion of Growth Hormone

> **NCT00271518** · PHASE3 · UNKNOWN · sponsor: **LG Life Sciences** · enrollment: 144 (estimated)

## Conditions studied

- Growth Hormone Deficiency (GHD)

## Interventions

- **DRUG:** growth hormone (somatropin)

## Key facts

- **NCT ID:** NCT00271518
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** 2013-12
- **Final completion:** —
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2010-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00271518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00271518, "Treatment of Children With Insufficient Secretion of Growth Hormone". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00271518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*